Skip to main content
ConductScienceScienceDex
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

12,799

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

12,799 results for “Immunization”

Learn how ShareScore rates datasets ↗
zenodo16/100

Evolutionary dynamics of proteinaceous MAMPs reveals intrabacterial antagonism of plant immune perception

<p>This submission contains Extended Figures, an&nbsp;HTML database,&nbsp;and raw experimental data from "<strong>Evolutionary dynamics of proteinaceous MAMPs reveals intrabacterial antagonism of plant immune perception" </strong>by Stevens et al. See file description for more information. Preprint DOI:&nbsp;https://doi.org/10.1101/2023.09.21.558511</p> <p>New data has been upload after manuscript revisions and the new running title is "Natural variation of immune epitopes reveals intrabacterial antagonism".</p>

openSep 2023View details →
zenodo16/100

IFN-γ signature as a peripheral blood biomarker for immune checkpoint inhibitors outcomes

Open the record for dataset details and reuse information.

restrictedcc-by-4.0Mar 2024View details →
zenodo16/100

Dataset related to article "Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy"

<p>This record contains data related to article&nbsp;&ldquo;Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy&quot;.&nbsp;</p> <p>A considerable proportion of cancer patients are resistant or only partially responsive to immune checkpoint blockade immunotherapy. Tumor-Associated Macrophages (TAMs) infiltrating the tumor stroma suppress the adaptive immune responses and, hence, promote tumor immune evasion. Depletion of TAMs or modulation of their protumoral functions is actively pursued, with the purpose of relieving this state of immunesuppression. We previously reported that trabectedin, a registered antitumor compound, selectively reduces monocytes and TAMs in treated tumors. However, its putative effects on the adaptive immunity are still unclear. In this study, we investigated whether treatment of tumor-bearing mice with trabectedin modulates the presence and functional activity of T-lymphocytes. In treated tumors, there was a significant upregulation of T cell-associated genes, including CD3, CD8, perforin, granzyme B, and IFN-responsive genes (MX1, CXCL10, and PD-1), indicating that T lymphocytes were activated after treatment. Notably, the mRNA levels of the Pdcd1 gene, coding for PD-1, were strongly increased. Using a fibrosarcoma model poorly responsive to PD-1-immunotherapy, treatment with trabectedin prior to anti-PD-1 resulted in improved antitumor efficacy. In conclusion, pretreatment with trabectedin enhances the therapeutic response to checkpoint inhibitor-based immunotherapy. These findings provide a good rational for the combination of trabectedin with immunotherapy regimens.</p> <p>&nbsp;</p>

restrictedDec 2021View details →
zenodo16/100

Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of IDH1 wild-type GBM

<p><a href="https://zenodo.org/api/files/3b61d9b7-5c0c-4f49-acae-5ec3c5294b1e/Original%20data-Construction%20of%20a%20necroptosis-related%20lncRNA%20signature.zip">Original data</a>:Construction of a necroptosis-related lncRNA signature to &nbsp;predict the prognosis and immune microenvironment of IDH1 wild-type GBM.</p>

restrictedAug 2022View details →
zenodo16/100

Dataset related to article: Prognostic Potential of Immune Inflammatory Biomarkers in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

<p>Systemic inflammation is associated with increased aggressiveness of breast cancer and can contribute to decreased activity of neoadjuvant treatments. Biomarkers of systemic inflammation are easily obtained from routine blood count and are highly cost-effective, having great potential to steer cancer prognosis in clinical practice. In our study we tested the hypothesis that high values of these biomarkers might have an effect on clinical outcomes in a population of patients treated with neoadjuvant chemotherapy for breast cancer. Results of our study, together with data from the literature, hint at a possible role of inflammatory markers in the diagnostic and therapeutic algorithm of breast cancer, where specific pre-operative blood cell ratios could be used in combination with biological and clinical factors to tailor adjuvant therapy.</p>

restrictedOct 2022View details →
zenodo16/100

Sex-related changes in LDH-A expression differently impact on immune response in melanoma

<p><span>Marta Iozzo1, Giuseppina Comito1, Luigi Ippolito1, Giada Sandrini2, Elisa Pardella1, Erica Pranzini1,<strong> </strong>Mariaelena Capone3, Gabriele Madonna3, Paolo Antonio Ascierto3, Paola Chiarugi1, Elisa Giannoni1.</span></p> <p><span>1 Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy</span></p> <p><span>2 Institute of Oncology Research (IOR), Universit&agrave; della Svizzera Italiana (USI), Bellinzona, Switzerland</span></p> <p><span>3 Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131, Naples, Italy </span></p> <p>&nbsp;</p> <p>Abstract<br>Melanoma incidence and mortality are higher in male patients than female ones, likely associated to the sex dimorphism in immune responses. Pro- and anti-tumor immune immunity are altered by the metabolic changes occurring in the tumor microenvironment.<br>Here, we identified the lactate dehydrogenase A (LDH-A), the key enzyme deputed to the lactate production, as a crucial metabolic player discriminating sex-related melanoma immune responses both in in vitro and in patient-derived specimens. Specifically, LDH-A-associated higher lactate secretion in male melanoma cells leads to a significant enrichment in pro-tumoral regulatory T cells (Treg) with a decrease in the number and activity of anti-tumor CD8+ T cells. Remarkably, pharmacological and genetic impairment of LDH-A in male melanoma cells are able to phenocopy female ones in terms of Treg and CD8+ infiltration. In keeping, in vivo pharmacological targeting of LDH-A in melanoma-bearing male mice significantly impairs tumor growth and lung colonization, and this correlates with a concomitant modulation of Treg and CD8+ T cells infiltration. Taken together, our findings underline sex-related differences in the melanoma LDH-A-promoting immune reshaping and suggest LDH-A targeting as an effective strategy to abolish the sex-gap in melanoma progression.</p> <p>&nbsp;</p>

restrictedcc-by-4.0Mar 2024View details →
zenodo16/100

Single-cell spatial profiling of small cell lung cancer suggests clinical outcome related tumor heterogeneity and immune colony niche

<p>High-dimension processed tif images of the publication "<strong>Spatial evolution and colony landscape of small cell lung cancer</strong>". The code used to produce the results of this study is available at <a href="https://github.com/ wangjun-hub/CODEX_SCLC">https://github.com/ wangjun-hub/CODEX_SCLC</a>.</p>

restrictedcc-by-4.0May 2024View details →
zenodo16/100

Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer

<p>The dataset contains the imaging mass cytometry data associated with Enfield et al.,&nbsp;<em>Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer.</em></p> <p>The patient and sample information has been previously described in Frankell <em>et al.</em>, <em>The evolution of lung cancer and impact of subclonal selection in TRACERx </em>and has been deposited on https://zenodo.org/records/7822002.</p> <p>A description of the deposited raw and process data is provided on https://tracerx-phlex.readthedocs.io/en/main/quickstart.html#data-repository.</p>

restrictedcc-by-4.0Jun 2024View details →
zenodo16/100

Age-related dynamics and spectral characteristics of the TCRβ repertoire in healthy children: implications for immune aging

<p><strong><span>Background: </span></strong><span>The T cell receptor (TCR) is crucial for adaptive immunity, providing a diverse repertoire for antigen response. However, despite its clinical importance, baseline characterization of the TCR in the pediatric population remains limited.</span></p> <p><strong><span>Methods:</span></strong><span> We conducted TCR<span>&beta;</span> sequencing on 325 healthy Chinese children aged 0-18 years, categorized into six age groups, to understand dynamic changes and establish a reference database of TCR<span>&beta;</span> rearrangements for this demographic. Furthermore, we used cell sorting on 81 samples with flow cytometry to analyze cellular composition and associations, focusing specifically on age-related variations in the TCR&beta; repertoire.</span></p> <p><strong><span>Results: </span></strong><span>Our study revealed an age-related decline in TCR&beta; repertoire diversity, marked by increased high-frequency and in-frame clonotypes. This shift in diversity is likely due to age-related variations in CDR3 length and V(D)J gene usage. The analysis of dynamic clonal changes in TCR&beta;, especially in public clones, suggests a link to perinatal influences and the immune system's evolving personalization. Early-life vaccinations and antigen exposures play a pivotal role in shaping this immune evolution. Notably, a significant association was found between the decrease of CD4<sup>+</sup> T naive cells and the diminishing TCR&beta; repertoire diversity along with age. Furthermore, our predictive models highlight specific TCR&beta; features as potential biomarkers for biological age, supported by their significant correlation.</span></p> <p><strong><span>Conclusion: </span></strong><span>This study provides essential insights into age-related variations in the TCR&beta; repertoire among children, enriching our understanding of pediatric immune system evolution and informing potential disease prevention strategies.</span></p>

restrictedcc-by-4.0Jul 2024View details →
zenodo16/100

A systems immunology approach reveals distinct roles of genetic and non-genetic factors in shaping variation of immune responses in cattle

<p>The VCF file contains 11486822 SNPs from 246 Belgian blue bulls utilized in a genome-wide association study focusing on immunophenotypes.</p>

restrictedcc-by-4.0Jul 2024View details →
zenodo16/100

The clinical significance of inflammatory biomarkers, IL6 cytokine, and systemic immune inflammatory index in rabbit model of acute and chronic Methicillin-resistant Staphylococcus epidermidis-induced osteomyelitis

Open the record for dataset details and reuse information.

restrictedcc-by-4.0Sep 2024View details →
zenodo16/100

Supplementary tables of Causal relationship between gut microbiota, blood metabolites, immune cell traits, inflammatory proteins, and cataract: a two-sample, bidirectional mendelian randomization analysis

<p><span>Table S1: The information of GWAS data for gut microbiota; Table S2: The information of GWAS data for blood metabolites and metabolite ratios; Table S3: The information of GWAS data for immune cell traits; Table S4: The information of GWAS data for circulating inflammatory proteins; Table S5: The results of casual effects and sensitive analysis of identified gut microbiota on cataract; Table S6: The results of casual effects and sensitive analysis of identified blood metabolites and metabolite ratios on cataract; Table S7: The results of casual effects and sensitive analysis of identified immune cell traits on cataract; Table S8: The results of casual effects and sensitive analysis of identified circulating inflammatory proteins on cataract; Table S9: The significant casual effects of two-sample MR analysis in mediation analysis; Table S10: The consistent effect sizes of exposure-outcome, exposure-mediator, and mediator-outcome; Table S11: The results of preliminary MVMR in mediation analysis; Table S12: The results of subsequent MVMR in mediation analysis; Table S13: The results of significant casual effects of cataract on gut microbiota, blood metabolites and metabolite ratios, and circulating inflammatory proteins; Table S14: The genes identified from the causal SNPs using MAGMA; Table S15: The results of functional enrichment analysis of the genes identified from the causal SNPs.</span></p>

restrictedcc-by-4.0Sep 2024View details →
zenodo16/100

Dataset related to article "Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases"

<p>This record contains data related to article &quot;Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases&quot;</p> <p>The purpose of this study was to evaluate the efficacy and safety of the Moderna-1273 mRNA vaccine for SARS-CoV-2 in patients with immune-mediated diseases under different treatments. Anti-trimeric spike protein antibodies were tested in 287 patients with rheumatic or autoimmune diseases (10% receiving mycophenolate mofetil, 15% low-dose glucocorticoids, 21% methotrexate, and 58% biologic/targeted synthetic drugs) at baseline and in 219 (76%) 4 weeks after the second Moderna-1273 mRNA vaccine dose. Family members or caretakers were enrolled as the controls. The neutralizing serum activity against SARS-CoV-2-G614, alpha, and beta variants in vitro and the cytotoxic T cell response to SARS-CoV-2 peptides were determined in a subgroup of patients and controls. Anti-SARS-CoV-2 antibody development, i.e., seroconversion, was observed in 69% of the mycophenolate-treated patients compared to 100% of both the patients taking other treatments and the controls (p&nbsp;&amp;amp;lt; 0.0001). A dose-dependent impairment of the humoral response was observed in the mycophenolate-treated patients. A daily dose of &amp;amp;gt;1 g at vaccination was a significant risk factor for non-seroconversion (ROC AUC 0.89, 95% CI 0.80-98,&nbsp;p&nbsp;&amp;amp;lt; 0.0001). Moreover, in the seroconverted patients, a daily dose of &amp;amp;gt;1 g of mycophenolate was associated with significantly lower anti-SARS-CoV-2 antibody titers, showing slightly reduced neutralizing serum activity but a comparable cytotoxic response compared to other immunosuppressants. In non-seroconverted patients treated with mycophenolate at a daily dose of &amp;amp;gt;1 g, the cytotoxic activity elicited by viral peptides was also impaired. Mycophenolate treatment affects the Moderna-1273 mRNA vaccine immunogenicity in a dose-dependent manner, independent of rheumatological disease.</p>

restrictedNov 2022View details →
ClinicalTrials.gov16/100

Changes in the Permeability of the Blood Brain Barrier and Intestinal Barrier in Humans During Conditions of Stress and Immune Activation: in Vivo Studies

ClinicalTrials.gov study NCT01417416. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov16/100

Change of Immune Cell of ARDS Patients:an Observational Study

ClinicalTrials.gov study NCT02958748. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov16/100

Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

ClinicalTrials.gov study NCT00001046. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov16/100

Withdrawal of Antifungal Treatment for Histoplasmosis in Patients After Improved Immune Response to Anti-HIV Drugs

ClinicalTrials.gov study NCT00006316. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov16/100

Effects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIV

ClinicalTrials.gov study NCT00021762. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov16/100

Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection

ClinicalTrials.gov study NCT00006630. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov16/100

The Effct of Chitooligosaccharide on Immune Function in Healthy Adults

ClinicalTrials.gov study NCT00468962. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.